07.30.24 -- Navigating ADC Manufacturing Complexity

Identifying the best CDMO partner is an integral component of many biopharma businesses. CDMOs can help mitigate the complexity and costs of drug substance development and drug product manufacturing.

Review key considerations as a Pharmatech Associates expert introduces a useful financial equation to calculate amortization to develop the business case for PCM and provides a few real-world cases.

Examine strategies to ensure both you and your CDMO are prepared to address the challenges of bringing a new biologic drug to market and discover the path towards a successful CDMO partnership

Recognizing what it takes to complete technology transfers effectively and efficiently is crucial to selecting the best partner for your project and product needs.

Examine the challenges CGT innovators face and how adhering to GMP requirements from an early stage helps ensure successful downstream applications from early clinical development to commercial phase.

Learn how a recent expansion into Western Pennsylvania is aiming to enable more biopharmaceutical firms to translate cutting-edge science and research into practical applications.

Capacity constraints typically are accompanied by other challenges, including missed timelines, defect rates, and overall decreased satisfaction with pharma companies’ bioprocessing CDMOs.

Nanoplasmids have paved the way for facilitating a wide range of cell and gene therapeutic applications. Gain an overview of a novel technology and specific benefits.